BREAKTHROUGHS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPLICATIONS

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sector of biopharmaceuticals, presenting promising progress across different professional medical and industrial purposes. With its structural similarity to naturally derived human serum albumin, OsrHSA presents a safer, much more reliable option for therapeutic